Toshiba Corp presents a technology for an early cancer detection


Toshiba Corp. has developed technology which detects 13 types of cancer from a single drop of blood.
Technology examines the types and concentration of microRNA molecules secreted in blood from cancer cells.
Device possibly will be used in health checkups, if preceded by a successful trial.
Technology could be used to treat cancer in its early stages.

Technology's advantages in the industry are 99% accuracy, 2 hour detection time, obtainable cost

Mentioned in this article:

Resource National Cancer Institute (NCI) - Institute for cancer research.

Resource Toshiba Corporation - The Tokyo-based Toshiba Corporation, is a diversified manufacturer and marketer of advanced electronic and electrical products

Read full article on Japan Times website
More Cancer information, news and resources
More Precision Medicine information, news and resources